X4制药(XFOR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XFOR X4制药

交易中 07-09 10:23:31 EDT

1.73

+0.07

+3.90%

最高1.79	最低1.69	成交量8.97万
今开1.70	昨收1.67	日振幅6.01%
总市值1,001万	流通市值951.50万	总股本578.87万
成交额15.48万	换手率1.63%	流通股本550.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"XFOR","market":"US","secType":"STK","nameCN":"X4制药","latestPrice":1.73,"timestamp":1752070828779,"preClose":1.665,"halted":0,"volume":89697,"delay":0,"floatShares":5499982,"shares":5788700,"eps":2.164116,"marketStatus":"交易中","change":0.065,"latestTime":"07-09 10:23:31 EDT","open":1.7,"high":1.79,"low":1.69,"amount":154771.8954393,"amplitude":0.06006,"askPrice":1.76,"askSize":200,"bidPrice":1.72,"bidSize":212,"shortable":3,"etf":0,"ttmEps":2.164116,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752091200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1510808400000,"exchange":"NASDAQ","adjPreClose":1.665,"preHourTrading":{"tag":"盘前","latestPrice":1.7198,"preClose":1.665,"latestTime":"09:17 EDT","volume":4530,"amount":7830.694353,"timestamp":1752067065071},"postHourTrading":{"tag":"盘后","latestPrice":1.7499,"preClose":1.665,"latestTime":"19:39 EDT","volume":6869,"amount":11693.5002,"timestamp":1752017940721},"volumeRatio":1.274636,"impliedVol":0.72,"impliedVolPercentile":0.2736},"requestUrl":"/m/hq/s/XFOR","defaultTab":"news","newsList":[{"id":"2549620555","title":"X4制药盘中异动 早盘股价大跌5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549620555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549620555?lang=zh_cn&edition=full","pubTime":"2025-07-07 22:56","pubTimestamp":1751900178,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日22时56分，X4制药股票出现波动，股价快速跳水5.82%。截至发稿，该股报1.78美元/股，成交量13.3786万股，换手率1.86%，振幅6.83%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。X4制药股票所在的生物技术行业中，整体跌幅为0.27%。X4制药公司简介：X4 Pharmaceuticals Inc 是一家生物制药公司，开发和商业化用于治疗罕见免疫系统疾病的新疗法。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707225619a43c155b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707225619a43c155b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2548890504","title":"X4制药盘中异动 急速拉升5.88%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548890504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548890504?lang=zh_cn&edition=full","pubTime":"2025-07-02 21:36","pubTimestamp":1751463375,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日21时36分，X4制药股票出现波动，股价大幅上涨5.88%。截至发稿，该股报1.97美元/股，成交量5.0569万股，换手率0.70%，振幅1.61%。最近的财报数据显示，该股实现营业收入28.81百万美元，净利润282000.00美元，每股收益0.04美元，毛利23.80百万美元，市盈率0.90倍。X4制药股票所在的生物技术行业中，整体涨幅为0.12%。X4制药公司简介：X4 Pharmaceuticals Inc 是一家生物制药公司，开发和商业化用于治疗罕见免疫系统疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507022136159797575c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507022136159797575c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2547126090","title":"X4制药盘中异动 股价大涨6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547126090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547126090?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:45","pubTimestamp":1751291123,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时45分，X4制药股票出现波动，股价急速拉升6.01%。截至发稿，该股报1.94美元/股，成交量2.4315万股，换手率0.34%，振幅6.55%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.24%。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506302145239794aa38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506302145239794aa38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2546726064","title":"X4制药盘中异动 急速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546726064","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546726064?lang=zh_cn&edition=full","pubTime":"2025-06-28 03:36","pubTimestamp":1751052962,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日03时36分，X4制药股票出现异动，股价快速下挫5.00%。截至发稿，该股报1.90美元/股，成交量26.761万股，换手率3.73%，振幅7.74%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中，整体跌幅为0.69%。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506280336039791bf9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506280336039791bf9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2546737979","title":"X4制药盘中异动 临近午盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546737979","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546737979?lang=zh_cn&edition=full","pubTime":"2025-06-26 23:35","pubTimestamp":1750952128,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日23时35分，X4制药股票出现异动，股价大幅下挫5.21%。截至发稿，该股报2.00美元/股，成交量11.028万股，换手率1.54%，振幅5.69%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.12%。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062623352897901c24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062623352897901c24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2546258837","title":"X4制药盘中异动 急速跳水5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546258837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546258837?lang=zh_cn&edition=full","pubTime":"2025-06-25 03:18","pubTimestamp":1750792705,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日03时18分，X4制药股票出现异动，股价大幅下跌5.37%。截至发稿，该股报2.29美元/股，成交量35.0555万股，换手率6.06%，振幅9.86%。X4制药股票所在的生物技术行业中，整体涨幅为2.04%。X4制药公司简介：X4 Pharmaceuticals Inc 是一家生物制药公司，开发和商业化用于治疗罕见免疫系统疾病的新疗法。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625031826a4bbf787&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625031826a4bbf787&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2545443846","title":"X4制药盘中异动 早盘股价大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545443846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545443846?lang=zh_cn&edition=full","pubTime":"2025-06-23 22:49","pubTimestamp":1750690183,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日22时49分，X4制药股票出现异动，股价急速下跌5.43%。截至发稿，该股报2.53美元/股，成交量6.4195万股，换手率1.11%，振幅5.73%。X4制药股票所在的生物技术行业中，整体涨幅为0.32%。X4制药公司简介：X4 Pharmaceuticals Inc 是一家生物制药公司，开发和商业化用于治疗罕见免疫系统疾病的新疗法。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623224943a7191a37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623224943a7191a37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2544155176","title":"X4制药盘中异动 股价大跌5.32%报2.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544155176","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544155176?lang=zh_cn&edition=full","pubTime":"2025-06-20 23:04","pubTimestamp":1750431865,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日23时04分，X4制药股票出现波动，股价大幅跳水5.32%。截至发稿，该股报2.67美元/股，成交量6.3137万股，换手率1.09%，振幅7.27%。最近的财报数据显示，该股实现营业收入28.81百万美元，净利润282000.00美元，每股收益0.04美元，毛利23.80百万美元，市盈率1.27倍。X4制药股票所在的生物技术行业中，整体跌幅为0.86%。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062023042697881edb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062023042697881edb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2544624905","title":"X4制药盘中异动 快速上涨6.57%报2.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544624905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544624905?lang=zh_cn&edition=full","pubTime":"2025-06-18 22:24","pubTimestamp":1750256695,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日22时24分，X4制药股票出现异动，股价快速上涨6.57%。截至发稿，该股报2.92美元/股，成交量3.0167万股，换手率0.52%，振幅5.11%。X4制药股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Aptevo Therapeutics Inc.、Immatics N V C/Wts 01/07/2025 、Biodexa Pharmaceuticals Plc涨幅较大，Aptevo Therapeutics Inc.、Biodexa Pharmaceuticals Plc、Nucana Plc较为活跃，换手率分别为8867.97%、853.68%、435.28%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Immatics N V C/Wts 01/07/2025 、Lixte Biotechnology Holdings, Inc.，振幅分别为140.07%、62.92%、42.34%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618222456a710aa62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618222456a710aa62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2544295604","title":"X4制药盘中异动 快速下挫5.30%报2.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544295604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544295604?lang=zh_cn&edition=full","pubTime":"2025-06-17 00:41","pubTimestamp":1750092074,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日00时41分，X4制药股票出现波动，股价快速下挫5.30%。截至发稿，该股报2.67美元/股，成交量56.5521万股，换手率9.77%，振幅9.92%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中，整体跌幅为0.49%。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617004114951eed37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617004114951eed37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2543542672","title":"X4制药盘中异动 大幅下挫5.15%报3.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543542672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543542672?lang=zh_cn&edition=full","pubTime":"2025-06-13 03:53","pubTimestamp":1749758035,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日03时53分，X4制药股票出现波动，股价急速跳水5.15%。截至发稿，该股报3.04美元/股，成交量18.2596万股，换手率3.15%，振幅4.68%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.64%。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506130353559519e718&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506130353559519e718&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2542607580","title":"X4制药盘中异动 早盘大幅跳水7.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542607580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542607580?lang=zh_cn&edition=full","pubTime":"2025-06-11 21:42","pubTimestamp":1749649366,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日21时42分，X4制药股票出现波动，股价急速下跌7.02%。截至发稿，该股报3.31美元/股，成交量5.8446万股，换手率1.01%，振幅2.81%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中，整体跌幅为0.06%。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611214247a703c40e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611214247a703c40e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2542317490","title":"X4制药盘中异动 股价大跌5.56%报3.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542317490","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542317490?lang=zh_cn&edition=full","pubTime":"2025-06-10 21:31","pubTimestamp":1749562279,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日21时31分，X4制药股票出现波动，股价快速下挫5.56%。截至发稿，该股报3.91美元/股，成交量121.7万股，换手率21.02%，振幅1.21%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.06%。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610213119a4a20552&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610213119a4a20552&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2541098760","title":"X4制药盘中异动 大幅上涨5.18%报4.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541098760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541098760?lang=zh_cn&edition=full","pubTime":"2025-06-05 01:15","pubTimestamp":1749057308,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日01时15分，X4制药股票出现波动，股价大幅拉升5.18%。截至发稿，该股报4.17美元/股，成交量11.3354万股，换手率1.96%，振幅8.84%。最近的财报数据显示，该股实现营业收入28.81百万美元，净利润282000.00美元，每股收益0.04美元，毛利23.80百万美元，市盈率1.97倍。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.57%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605011508a6fa8d09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605011508a6fa8d09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2540799173","title":"X4制药盘中异动 早盘股价大涨5.88%报3.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540799173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540799173?lang=zh_cn&edition=full","pubTime":"2025-06-02 22:22","pubTimestamp":1748874153,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日22时22分，X4制药股票出现异动，股价快速拉升5.88%。截至发稿，该股报3.60美元/股，成交量3.8967万股，换手率0.67%，振幅3.53%。最近的财报数据显示，该股实现营业收入28.81百万美元，净利润282000.00美元，每股收益0.04美元，毛利23.80百万美元，市盈率1.68倍。X4制药股票所在的生物技术行业中，整体涨幅为0.89%。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602222234a6f730f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602222234a6f730f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2539267040","title":"X4制药盘中异动 下午盘快速上涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539267040","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539267040?lang=zh_cn&edition=full","pubTime":"2025-05-30 01:23","pubTimestamp":1748539385,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日01时23分，X4制药股票出现波动，股价急速上涨5.23%。截至发稿，该股报3.42美元/股，成交量4.6336万股，换手率0.80%，振幅5.23%。X4制药股票所在的生物技术行业中，整体涨幅为1.35%。X4制药公司简介：X4 Pharmaceuticals Inc 是一家生物制药公司，开发和商业化用于治疗罕见免疫系统疾病的新疗法。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053001230595072967&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053001230595072967&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2537913240","title":"X4制药盘中异动 急速下跌5.88%报3.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537913240","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537913240?lang=zh_cn&edition=full","pubTime":"2025-05-23 21:50","pubTimestamp":1748008225,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日21时50分，X4制药股票出现异动，股价大幅下挫5.88%。截至发稿，该股报3.04美元/股，成交量2.7476万股，换手率0.47%，振幅4.80%。最近的财报数据显示，该股实现营业收入28.81百万美元，净利润282000.00美元，每股收益0.04美元，毛利23.80百万美元，市盈率1.47倍。X4制药股票所在的生物技术行业中，整体跌幅为0.09%。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523215025a489c9c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523215025a489c9c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2537928192","title":"X4制药盘中异动 大幅拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537928192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537928192?lang=zh_cn&edition=full","pubTime":"2025-05-22 23:25","pubTimestamp":1747927553,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日23时25分，X4制药股票出现波动，股价急速拉升5.05%。截至发稿，该股报2.91美元/股，成交量9.8502万股，换手率1.70%，振幅6.94%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中，整体跌幅为0.67%。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522232553a6e90c1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522232553a6e90c1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2536645110","title":"X4制药盘中异动 快速跳水6.51%报2.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536645110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536645110?lang=zh_cn&edition=full","pubTime":"2025-05-20 22:00","pubTimestamp":1747749653,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日22时00分，X4制药股票出现波动，股价大幅下挫6.51%。截至发稿，该股报2.73美元/股，成交量2.8655万股，换手率0.50%，振幅5.48%。最近的财报数据显示，该股实现营业收入28.81百万美元，净利润282000.00美元，每股收益0.04美元，毛利23.80百万美元，市盈率1.32倍。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.34%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052022005394fccb2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052022005394fccb2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2535822110","title":"X4制药盘中异动 早盘急速跳水5.24%报3.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535822110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535822110?lang=zh_cn&edition=full","pubTime":"2025-05-15 22:13","pubTimestamp":1747318439,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日22时13分，X4制药股票出现异动，股价大幅下挫5.24%。截至发稿，该股报3.07美元/股，成交量5.1859万股，换手率0.90%，振幅4.62%。最近的财报数据显示，该股实现营业收入28.81百万美元，净利润282000.00美元，每股收益0.04美元，毛利23.80百万美元，市盈率1.46倍。X4制药股票所在的生物技术行业中，整体涨幅为0.35%。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515221400a6e077ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515221400a6e077ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.x4pharma.com","stockEarnings":[{"period":"1week","weight":-0.1048},{"period":"1month","weight":-0.6128},{"period":"3month","weight":-0.7608},{"period":"6month","weight":-0.9128},{"period":"1year","weight":-0.9045},{"period":"ytd","weight":-0.9243}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.0354},{"period":"3month","weight":0.1307},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.1172},{"period":"ytd","weight":0.0585}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"X4 Pharmaceuticals, Inc.于2010年8月2日根据特拉华州法律注册成立。该公司是一家晚期临床阶段的生物制药公司，发现和开发用于治疗罕见疾病和治疗选择有限的疾病的新疗法，重点关注免疫系统功能障碍导致的疾病。该公司的主要临床候选药物是mavorixafor，这是一种趋化因子受体CXCR4的小分子选择性拮抗剂，正在开发为一种口服、每日一次的疗法。由于mavorixafor能够增加成熟、功能性白细胞进入血液的动员，该公司认为mavorixafor有可能在多种慢性中性粒细胞减少症中提供治疗益处，包括WHIM（疣、低丙种球蛋白血症、感染和骨髓松弛症）综合征，这是一种罕见的原发性免疫缺陷。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.002706},{"month":2,"riseRate":0.625,"avgChangeRate":0.017263},{"month":3,"riseRate":0.5,"avgChangeRate":0.070477},{"month":4,"riseRate":0.25,"avgChangeRate":-0.02608},{"month":5,"riseRate":0.25,"avgChangeRate":-0.040791},{"month":6,"riseRate":0.125,"avgChangeRate":-0.268932},{"month":7,"riseRate":0.25,"avgChangeRate":-0.040849},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.090685},{"month":9,"riseRate":0.285714,"avgChangeRate":0.011165},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.121911},{"month":11,"riseRate":0.285714,"avgChangeRate":0.198506},{"month":12,"riseRate":0.375,"avgChangeRate":-0.068572}],"exchange":"NASDAQ","name":"X4制药","nameEN":"X4 Pharmaceuticals Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"X4制药(XFOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供X4制药(XFOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"X4制药,XFOR,X4制药股票,X4制药股票老虎,X4制药股票老虎国际,X4制药行情,X4制药股票行情,X4制药股价,X4制药股市,X4制药股票价格,X4制药股票交易,X4制药股票购买,X4制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"X4制药(XFOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供X4制药(XFOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}